PH22801A - 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same - Google Patents

1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same

Info

Publication number
PH22801A
PH22801A PH32174A PH32174A PH22801A PH 22801 A PH22801 A PH 22801A PH 32174 A PH32174 A PH 32174A PH 32174 A PH32174 A PH 32174A PH 22801 A PH22801 A PH 22801A
Authority
PH
Philippines
Prior art keywords
dihydro
salts
same
antibacterial agents
oxonaphthyridine derivatives
Prior art date
Application number
PH32174A
Other languages
English (en)
Inventor
Hirokazu Narita
Hideyoshi Nagaki
Isao Kitayama
Yoriko Kobayashi
Yasuo Watanabe
Shinzaburo Minami
Isamu Saikawa
Yoshinori Konishi
Jun Nitta
Mikako Shinagawa
Akira Yotsuji
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH22801(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of PH22801A publication Critical patent/PH22801A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
PH32174A 1984-04-26 1985-04-23 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same PH22801A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59084963A JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Publications (1)

Publication Number Publication Date
PH22801A true PH22801A (en) 1988-12-12

Family

ID=13845280

Family Applications (3)

Application Number Title Priority Date Filing Date
PH32174A PH22801A (en) 1984-04-26 1985-04-23 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same
PH35958A PH25046A (en) 1984-04-26 1987-10-20 A process for producing 1,4-duhydro-4-oxo-naphthyridine and salts thereof
PH35960A PH25228A (en) 1984-04-26 1987-10-20 A process for producing 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
PH35958A PH25046A (en) 1984-04-26 1987-10-20 A process for producing 1,4-duhydro-4-oxo-naphthyridine and salts thereof
PH35960A PH25228A (en) 1984-04-26 1987-10-20 A process for producing 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof

Country Status (30)

Country Link
JP (1) JPS60228479A (ja)
KR (1) KR870001693B1 (ja)
AR (1) AR241911A1 (ja)
AT (2) AT389698B (ja)
AU (2) AU565087B2 (ja)
BE (1) BE902279A (ja)
CH (1) CH673458A5 (ja)
CS (1) CS250684B2 (ja)
DD (1) DD238795A5 (ja)
DE (2) DE3514076A1 (ja)
DK (1) DK165877C (ja)
EG (1) EG17339A (ja)
ES (2) ES8700256A1 (ja)
FI (1) FI80453C (ja)
FR (2) FR2563521B1 (ja)
GB (2) GB2158825B (ja)
HU (2) HU197571B (ja)
ID (1) ID21142A (ja)
IL (1) IL75021A (ja)
IT (1) IT1209953B (ja)
LU (1) LU85871A1 (ja)
NL (2) NL187314C (ja)
NO (1) NO162238C (ja)
NZ (1) NZ211895A (ja)
PH (3) PH22801A (ja)
PL (1) PL147392B1 (ja)
PT (1) PT80349B (ja)
RO (2) RO95509B (ja)
SE (2) SE463102B (ja)
ZA (1) ZA853102B (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (ja) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd ピリジルケトン誘導体
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
ATE75740T1 (de) * 1985-06-26 1992-05-15 Daiichi Seiyaku Co Pyridoncarbonsaeurederivate.
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
AU1161492A (en) * 1991-01-14 1992-08-17 Hanmi Pharmaceutical Co., Ltd. Novel quinolone compounds and processes for preparation thereof
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
KR940014395A (ko) * 1992-12-09 1994-07-18 강박광 신규한 퀴놀론 유도체 및 그의 제조방법
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE69531305T2 (de) * 1994-10-20 2004-05-13 Wakunaga Seiyaku K.K. Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
WO1997040036A1 (fr) 1996-04-19 1997-10-30 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives de l'acide pyridonocarboxylique ou des sels de cet acide et agents antibacteriens contenant ces substances en tant que composant actif
KR20000052892A (ko) * 1996-10-30 2000-08-25 빌프리더 하이더 나프티리딘 화합물의 제조 방법 및 신규 중간 생성물
DE19713506A1 (de) 1997-04-01 1998-10-08 Bayer Ag Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere
KR100768034B1 (ko) 1999-03-17 2007-10-17 다이이찌 세이야꾸 가부시기가이샤 의약 조성물
US6441182B1 (en) 1999-06-10 2002-08-27 Bayer Aktiengesellschaft Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
WO2001017991A1 (fr) 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Derive d'acide quinolinecarboxylique ou son sel
EP1313708A1 (en) * 2000-08-29 2003-05-28 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법
CN101792443A (zh) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
CN114369092A (zh) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 甲苯磺酸妥舒沙星及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4382937A (en) * 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Also Published As

Publication number Publication date
RO91871B (ro) 1987-07-31
ATA267888A (de) 1989-09-15
GB8510297D0 (en) 1985-05-30
CH673458A5 (ja) 1990-03-15
PH25046A (en) 1991-01-28
FR2563521A1 (fr) 1985-10-31
DK185685D0 (da) 1985-04-25
CS250684B2 (en) 1987-05-14
NO162238C (no) 1989-12-06
ES542584A0 (es) 1986-09-16
GB2158825A (en) 1985-11-20
IT1209953B (it) 1989-08-30
AU612993B2 (en) 1991-07-25
PT80349B (pt) 1987-09-30
IT8548002A0 (it) 1985-04-26
DE3514076A1 (de) 1985-10-31
SE463102B (sv) 1990-10-08
FR2614620A1 (fr) 1988-11-04
FI851637A0 (fi) 1985-04-25
ES8706673A1 (es) 1987-07-01
GB2191776A (en) 1987-12-23
PL253108A1 (en) 1985-12-17
NZ211895A (en) 1988-07-28
IL75021A0 (en) 1985-08-30
HUT38634A (en) 1986-06-30
AT389698B (de) 1990-01-10
KR870001693B1 (ko) 1987-09-24
SE8804586L (sv) 1988-12-20
KR850007596A (ko) 1985-12-07
DK165877C (da) 1993-06-21
FI80453C (fi) 1990-06-11
IL75021A (en) 1994-01-25
SE8502017D0 (sv) 1985-04-25
RO91871A (ro) 1987-07-30
AU8180487A (en) 1988-03-24
FR2614620B1 (fr) 1990-03-09
GB2191776B (en) 1990-03-28
BE902279A (fr) 1985-10-25
GB8716897D0 (en) 1987-08-26
NL187314C (nl) 1991-08-16
DE3514076C2 (ja) 1989-03-30
DK185685A (da) 1985-10-27
SE8502017L (sv) 1985-10-27
AT390258B (de) 1990-04-10
FI80453B (fi) 1990-02-28
SE8804586D0 (sv) 1988-12-20
PH25228A (en) 1991-03-27
RO95509A (ro) 1988-09-30
ID21142A (id) 1999-04-29
AU565087B2 (en) 1987-09-03
RO95509B (ro) 1988-10-01
DD238795A5 (de) 1986-09-03
PL147392B1 (en) 1989-05-31
AR241911A1 (es) 1993-01-29
NO851643L (no) 1985-10-28
PT80349A (en) 1985-05-01
DK165877B (da) 1993-02-01
FI851637L (fi) 1985-10-27
JPS6320828B2 (ja) 1988-04-30
SE501412C2 (sv) 1995-02-13
HU197571B (en) 1989-04-28
ES8700256A1 (es) 1986-09-16
EG17339A (en) 1989-06-30
NL9100648A (nl) 1991-08-01
NO162238B (no) 1989-08-21
ZA853102B (en) 1986-12-30
LU85871A1 (en) 1985-12-16
GB2158825B (en) 1989-01-25
ES551538A0 (es) 1987-07-01
JPS60228479A (ja) 1985-11-13
FR2563521B1 (fr) 1989-02-03
AU4165085A (en) 1985-10-31
HU194226B (en) 1988-01-28
NL8501172A (nl) 1985-11-18
ATA122485A (de) 1989-06-15
DE3546658C2 (ja) 1992-04-02

Similar Documents

Publication Publication Date Title
PH22801A (en) 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same
EP0423358A4 (en) Postostatin and related compound thereof, or their salts
GB2153821B (en) 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives
AU568004B2 (en) Antibacterial 1,4 hydro-quinolines and 1,8-napthridines
PH22614A (en) 9-amino-1,2,3,4-tetrahydroacridin-1-alpha and related compounds and their use as medicament
AU566984B2 (en) Antibacterial 1,8-napthyridine and quinoune derivatives and their further fused analogues
PH23474A (en) Antibacterial agents
EP0202580A3 (en) 3,4-dihydrobenzopyran derivatives
DE3666820D1 (en) 5,6-difluoronaphthyridines and 5,6,8-trifluoro-quinolines as antibacterial agents
OA07955A (en) Antibacterial agents.
ZA869591B (en) Substituted 5,6-dialkoxyquinazoline derivatives
GB2173195B (en) N,n'-diaminocarbonylmethyl-n,n'-dicarboxymethyl-1,2-diaminoethane derivatives
EP0183975A3 (en) 5,6,7,8-tetrafluoroanthraquinone derivatives
GB2161161B (en) Antibacterial 7-oxo-4-thia-1-azabicyclo/o.3 2 0/-hept-2-ene derivatives
ZA85853B (en) Antibacterial agents
HK185395A (en) 9,11-Epoxy-21-hydroxypregnane derivatives
ZA851949B (en) 1,2,4-triazacycloalkadiene derivatives
IL85451A (en) 26, 27-mono- and 14,15:26,27-diepoxy g22-ll-f28249 derivatives and their pesticidal use
IL71769A0 (en) 4,4'-alkylenedipiperidine derivatives
NZ220339A (en) 2-phenylacetyl-1,3,5-cyclohexanetrione derivatives and herbicidal compositions
PH21777A (en) 3-mercapto-1,2,4-triazacycloalkadiene derivatives
GB2093024B (en) 2,4,8-triazaphenalenium salts and their preparation
GB8523735D0 (en) 1,2-benzoxathiine derivatives
GB2179350B (en) 7-oxo-4-thia-1-azabicyclo3.2.0hept-2-ene derivatives
IE841028L (en) 5,6-dihydropyran-2-one derivatives